Guest guest Posted July 17, 2007 Report Share Posted July 17, 2007 here are some delay news regarding fda approval of tasigma (amn-107) i hope the delay will not be longer than the 3 months reported best regards giora Reuters Novartis cuts outlook, faces U.S. Tasigna delay Tuesday July 17, 8:16 am ET Novartis also said U.S. regulators had extended their review period for cancer drug Tasigna by three months to review additional data. No new studies are required Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.